Restoring Wnt/β-catenin signaling is a promising therapeutic strategy for Alzheimer’s disease

Lin Jia,Juan Piña-Crespo,Yonghe Li
DOI: https://doi.org/10.1186/s13041-019-0525-5
2019-12-01
Molecular Brain
Abstract:Abstract Alzheimer’s disease (AD) is an aging-related neurological disorder characterized by synaptic loss and dementia. Wnt/β-catenin signaling is an essential signal transduction pathway that regulates numerous cellular processes including cell survival. In brain, Wnt/β-catenin signaling is not only crucial for neuronal survival and neurogenesis, but it plays important roles in regulating synaptic plasticity and blood-brain barrier integrity and function. Moreover, activation of Wnt/β-catenin signaling inhibits amyloid-β production and tau protein hyperphosphorylation in the brain. Critically, Wnt/β-catenin signaling is greatly suppressed in AD brain via multiple pathogenic mechanisms. As such, restoring Wnt/β-catenin signaling represents a unique opportunity for the rational design of novel AD therapies.
neurosciences
What problem does this paper attempt to address?